The level of price discounting for Stelara biosimilars has hit a new low (or high), depending on your point of view. Hikma Pharmaceuticals USA announced on November 6 that it has launched Starjemza, its ustekinumab biosimilar, manufactured by Bio-Thera Solutions. Yesterday, Mark Cuban’s Cost Plus Drug Company announced the availability of Starjemza’s low monthly price … Continue reading Mark Cuban’s 99% Discount on Ustekinumab Biosimilar